Physician profile
Scott Schulte
NPI 1285874263
$5,226.80
in general payments reported to CMS, 2019-2025
12 companies · $555 in 2025
The $555 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $759 · 2022: $2,018 · 2023: $1,126 · 2024: $769 · 2025: $555.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,262 · Travel and Lodging: $1,188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,261.85 |
| Travel and Lodging | $1,187.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,713.65 | 2022-2023 | Da Vinci Surgical System |
| Getinge USA Sales, LLC | $765.88 | 2021-2025 | Vasoview Hemopro 2, Vasoview Hemopro 2 |
| Atricure, INC. | $519.24 | 2021-2025 | Atriclip Laa Exclusion System |
| Abiomed | $391.24 | 2023-2025 | Impella |
| Astrazeneca Pharmaceuticals LP | $388.71 | 2021-2023 | Farxiga |
| Novo Nordisk INC | $116.51 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $97.72 | 2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $91.16 | 2023 | Camzyos |
| Edwards Lifesciences Corporation | $63.14 | 2022-2023 | |
| Corcym INC | $31.12 | 2021-2024 | Carbomedics Supra-Annular (Top Hat) |
| Irhythm Technologies, INC. | $28.75 | 2022 | |
| Zimmer Biomet Holdings, INC. | $19.68 | 2023 | Sternalock 360 System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Schulte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.